UNSPSC 51102876: Ambroxol/cefadroxil
Commodity
Code facts
- Part of
-
-
51000000
-
51100000
- 51102800
-
51100000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51102876
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes a combination drug composed of two constituents: a mucolytic and a cephalosporin antibiotic, as more fully appears.
The first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula C13H18BR2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 200168S0CL, chemically known as 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [EU/ESIS 242-500-3]; ambroxol comes in forms acefyllinate [0HM1E174TN], base, and hydrochloride [CC995ZMV90].
Read the full definition
European Medicines Agency schedules AMBROXOL in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05397MIG (base), SUB12842MIG (acefyllinate), and SUB00427MIG (hydrochloride). The term AMBROXOL is an International Non-Proprietary Name or INN. World Health Organization schedules ambroxol in its Anatomical Therapeutic Chemical (ATC) Classification (R05CB06) and in its WHO Drug Dictionary. AMBROXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Most nations schedule ambroxol under HS 29221980 and SITC 51461. US Census, for industry purposes, classifies ambroxol under NAICS 325199.
The second constituent, Cefadroxil (51282502), is a cephalosporin antibiotic with the molecular formula C16H17N3O5S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 280111G160, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefadroxil, which bears US NIH Compound Identifier 2610. Cefadroxil most often comes in base, hydrate, and hemihydrate forms.
European Medicines Agency schedules Cefadroxil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06164MIG. World Health Organization schedules cefadroxil in its Anatomical Therapeutic Chemical (ATC) Classification. CEFADROXIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefadroxil under HS 29419000 and SITC 54139. As of Q4 2014, CEFADROXIL remains the US FDA Preferred Term for this commodity.
Cefadroxil bears US NLM identifiers UMLS ID C0007538 and NCI Concept Code C28912.
About UNSPSC 51102876
UNSPSC 51102876 Ambroxol/cefadroxil (Commodity) does not align with the state and local procurement activity actually tagged under this code. The code nominally identifies a specific pharmaceutical combination product, but recent opportunities posted against it describe procurement of unrelated medications including doxycycline, ciprofloxacin, and naloxone—distinct active pharmaceutical ingredients with different therapeutic uses and no formulation connection to ambroxol or cefadroxil. This mismatch suggests either tagging errors in the state and local procurement systems or a misalignment between the code's scope and how jurisdictions classify pharmaceutical purchases. The code shows minimal relevant recent activity grounded in its stated commodity definition.
The Illinois Department of Public Health awarded a completed pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for doxycycline and ciprofloxacin tablets totaling $2,999,999.11 over the contract life including renewal periods; separately, Seminole County, Florida released an IFB on June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly delivery to the Seminole County Community Health Building and a response deadline of July 26, 2023. Neither opportunity reflects purchasing under the code's stated ambroxol/cefadroxil scope. State and local buyers using this code should verify that procurement systems are tagging pharmaceutical opportunities against the correct UNSPSC classifications; business development professionals should monitor whether activity under this code becomes more aligned with its nominal scope or remains misclassified.
Quick answers
What is UNSPSC 51102876?
UNSPSC 51102876 is Ambroxol/
Which NIGP codes match UNSPSC 51102876?
UNSPSC 51102876 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51102876
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code